Open-access Fine Particulate Pollution is a Powerful Risk Factor for Cardiovascular Disease

Keywords
Air Pollution; Particulate Matter; Cardiovascular Diseases

Palavras-chave
Poluição do Ar; Material Particulado; Doenças Cardiovasculares

Keywords
Air Pollution; Particulate Matter; Cardiovascular Diseases

Palavras-chave
Poluição do Ar; Material Particulado; Doenças Cardiovasculares

In this issue, Moura PH et al1 found that the Rio de Janeiro Metropolitan area, RJ, BR presents out-of-limit high levels of air pollution and there was a direct correlation between air pollution with PM2.5 (Particulate Matter of 2.5 μm) and higher incidence of cardiovascular disease, especially in lower socioeconomic status and in the elderly.

Since the Framingham Study had enumerated the so-called traditional risk factors – hypertension, high LDL-cholesterol, low HDL-cholesterol, diabetes, tobacco smoking, obesity, sedentary lifestyle, and male sex – a growing number of risk factors have been continuously added to that list.2

The concept of atherosclerosis as a chronic inflammatory disease1 has linked all risk factors to its initiation, growth, and complications such as chronic and acute coronary syndrome, stroke, and peripheral vascular disease.

All begins with endothelial activation or inflammation, resulting in the production and exposure of adhesion molecules (selectins, integrins), Intercellular Adhesion Molecule-1 (ICAM-1), and Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1). That is followed by monocytes and lymphocytes migration to the sub-intimal space, promoting production of cytokines and chemokines, growth factors, and matrix metalloproteinases (MMP), and migration of vascular smooth muscle cells. Ending in lesion growth and thrombotic complications by rupture or erosion.

How is air pollution measured by PM2.5 inserted in this scenario?

PM is a complex mixture of inhaled solid particles and gaseous matter, with a variable composition from natural sources: wildfires and sand dust storms, to anthropogenic sources: combustion of fossil fuel, transportation, and industrial processes.

The worst PM are of 2.5 micrometers because they can reach to lung and enter the systemic blood circulation and elicits systemic inflammation process.3

The Global Burden of Disease 2019 report has shown air pollution in the fourth position of risk of all-cause mortality, only overcome by hypertension, tobacco, and dietary risk. Above high fasting plasma glucose, high body-mass index, high LDL-cholesterol, and kidney dysfunction.4

A meta-analysis of 11 European cohort studies showed a 13% increase in acute coronary syndrome events with a 5 μg/m3 increase in the estimated annual mean PM2.5 exposure and a 12% increase in acute coronary syndrome events with a10 μg/m3 increase in the estimated annual mean PM10.5

Even short-term exposure to PM is also linked to an increased incidence of acute myocardial infarction (AMI), mainly ST-segment elevation AMI, and related mortality, particularly in elderly patients with preexisting CAD and significant risk factors for CVD.6

A recent study found that the HR for all cerebrovascular events was 2.14 times higher when comparing the top vs bottom quartiles of PM2.5.7

Besides being a direct cardiovascular risk factor, PM2.5 is also a marker of other air pollutants such as ozone, carbon monoxide, nitrogen oxides, sulfur oxides, and lead. All are also related to systemic inflammation, oxidative stress, and endothelial dysfunction, and eventually atherosclerosis.

In addition to atherosclerotic potential, PM2.5 acts on traditional risk factors, increasing their atherogenic power.

Living air environment, both indoor and outdoor, and the workplace, is a public health problem, and major enforcement has to be made for its control for better care, which may contribute to a more complete approach to health care.

  • Short Editorial related to the article:
    Impact of PM2.5 Air Pollution on Mortality from Circulatory System Diseases in the Neighborhoods of the City of Rio de Janeiro (2000-2019)

References

  • 1 Moura PH, Carvalho LDG, Godoy PH. Impact of PM2.5 Air Pollution on Mortality from Circulatory System Diseases in the Neighborhoods of the City of Rio de Janeiro (2000-2019). Arq Bras Cardiol. 2026; 123(1):e20250459. doi: 10.36660/abc.20250459.
    » https://doi.org/10.36660/abc.20250459
  • 2 Ross R. Atherosclerosis--An Inflammatory Disease. N Engl J Med. 1999;340(2):115-26. doi: 10.1056/NEJM199901143400207.
    » https://doi.org/10.1056/NEJM199901143400207
  • 3 Bevan GH, Al-Kindi SG, Brook RD, Münzel T, Rajagopalan S. Ambient Air Pollution and Atherosclerosis: Insights Into Dose, Time, and Mechanisms. Arterioscler Thromb Vasc Biol. 2021;41(2):628-37. doi: 10.1161/ATVBAHA.120.315219.
    » https://doi.org/10.1161/ATVBAHA.120.315219
  • 4 GBD 2019 Risk Factors Collaborators. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396(10258):1223-49. doi: 10.1016/S0140-6736(20)30752-2.
    » https://doi.org/10.1016/S0140-6736(20)30752-2
  • 5 Cesaroni G, Forastiere F, Stafoggia M, Andersen ZJ, Badaloni C, Beelen R, et al. Long Term Exposure to Ambient Air Pollution and Incidence of Acute Coronary Events: Prospective Cohort Study and Meta-Analysis in 11 European cohorts from the ESCAPE Project. BMJ. 2014;348:f7412. doi: 10.1136/bmj.f7412.
    » https://doi.org/10.1136/bmj.f7412
  • 6 Cai X, Li Z, Scott EM, Li X, Tang M. Short-Term Effects of Atmospheric Particulate matter on Myocardial Infarction: A Cumulative Meta-Analysis. Environ Sci Pollut Res Int. 2016;23(7):6139-48. doi: 10.1007/s11356-016-6186-3.
    » https://doi.org/10.1007/s11356-016-6186-3
  • 7 Bo Y, Zhu Y, Zhang X, Chang H, Zhang J, Lao XQ, et al. Spatiotemporal Trends of Stroke Burden Attributable to Ambient PM2.5 in 204 Countries and Territories, 1990-2019: A Global Analysis. Neurology. 2023;101(7):e764-e776. doi: 10.1212/WNL.0000000000207503.
    » https://doi.org/10.1212/WNL.0000000000207503

Publication Dates

  • Publication in this collection
    16 Mar 2026
  • Date of issue
    Jan 2026

History

  • Received
    04 Jan 2026
  • Reviewed
    06 Jan 2026
  • Accepted
    06 Jan 2026
location_on
Sociedade Brasileira de Cardiologia - SBC Avenida Marechal Câmara, 160, sala: 330, Centro, CEP: 20020-907, (21) 3478-2700 - Rio de Janeiro - RJ - Brazil, Fax: +55 21 3478-2770 - São Paulo - SP - Brazil
E-mail: revista@cardiol.br
rss_feed Acompanhe os números deste periódico no seu leitor de RSS
Ir para o topo Reportar erro